Skip to main content
Current Oncology logoLink to Current Oncology
. 2013 Oct;20(5):e492. doi: 10.3747/co.20.1731

Preventing ovarian cancer by salpingectomy

WD Foulkes
PMCID: PMC3805420

Original Citation

Curr Oncol 2013;20:139–42.

(doi: http://dx.doi.org/10.3747/co.20.1613)

Author Description of the Error and Correction

An error was made in the text of the paper (p. 139, col. 1, under the subheading The Origins of High-Grade Ovarian Carcinoma). The sentence

Further studies have confirmed that in situ serous tubal carcinomas are present in between 60% and 100% of preventive oophorectomy specimens from women with BRCA1 or BRCA2 mutations, but also that such disease is seen in the excised fallopian tubes of 30%–60% of women with high-grade serous carcinomas who do not carry BRCA1/2 mutations.

should read

Further studies have confirmed that in situ serous tubal carcinomas are present in approximately 8%–12% of preventive salpingo-oophorectomy specimens from women with BRCA1 or BRCA2 mutations, but also that such disease is seen in the excised fallopian tubes of 30%–60% of women with high-grade serous carcinomas who do not carry BRCA1/2 mutations.

I thank Dr. T. Colgan for bringing this error to my attention.


Articles from Current Oncology are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES